abemaciclib 200 MG Oral Tablet

RxCUI
1946846
RxNorm name
abemaciclib 200 MG Oral Tablet
Display name
abemaciclib 200 MG Oral Tablet
Full name
abemaciclib 200 MG Oral Tablet
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:19

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
VerzenioABEMACICLIBEli Lilly and Companybe4bc0de-0fdc-4d46-8d25-be43c79e6a062026-07-13Warnings, Adverse reactionsExact identifier
rxcui: 1946846

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
be4bc0de-0fdc-4d46-8d25-be43c79e6a06abemaciclib 200 MG Oral Tablet [PSN] · abemaciclib 200 MG Oral Tablet [SCD]227These highlights do not include all the information needed to use VERZENIO safely and effectively. See full prescribing information for VERZENIO. VERZENIO ® (abemaciclib) tablets, for oral use Initial U.S. Approval: 201720250825